Diagwrite focuses on last mile connectivity in the diagnostic process to reduce errors

Mumbai: The Indian diagnostics industry has been growing rapidly over the years, which has proved to be one of the important components of the healthcare sector, as medical professionals rely on diagnostic statements for accurate diagnosis and correct treatment of diseases.

Despite the presence of thousands of laboratories and lakhs of lab technicians, the industry fails to meet the needs of the consumers, as the ecosystem is highly disorganized and fragmented. According to NCBI (National Center of Biotechnology Information), 61.9 per cent of the total lab tests conducted in India were wrong. Pre-analytical errors and logistical challenges associated with sample collection for sample testing in laboratories are a major contributor to this.

To address issues regarding analytical errors, last mile delivery and evaluation of samples, Gurgaon-based health tech startup Diagrite is entering the market and bringing innovation to the clinical industry with a first-of-its-kind hyperlocal model.

Established in the year 2020, Diagrite is envisaged to standardize last mile delivery and reduce the scope for pre-analytical errors, Diagrite has managed to become a changemaker within a year of its operation.

Co-founder and CEO Asitranjan Vishwabhushan clearly states that the demand for medical tests is huge, while the challenge remains in the clinical ecosystem. He also said that despite the huge demand for diagnostic tests, there is a shortage of trained technicians and the process is largely non-standardized and unstructured. Thus, Diagrite claims to be the most promising health-tech startup to create awareness about diagnostic rights for citizens of India.

To bridge the supply and demand gap, Diagrite is strictly adhering to the National Accreditation Board of Testing and Calibration Laboratories (NABL) India guidelines and standardizing the last mile connectivity of the phlebotomist with the use of technology. Adherence to and follow treatment protocols by doctors is essential to reduce errors in the diagnostic process, as 70 percent of all decisions regarding treatment depend entirely on correct diagnosis.

Puneet Sharma, Co-Founder and COO, says that the Home Blood Sample Collection App enables consumers to choose any lab within a 10 km radius to meet their clinical requirement. Customers have the option to customize the look of their diagnostic package. Details of laboratory pricing for various tests are issued to the customers along with the option. You will get all these by clicking on the app while sitting at home.

The DiGrite technology developed by TrackWrite ensures that the sample temperature is below 8 °C to maintain accuracy. The real-time technology also allows customers to check the temperature of the sample at any time on the app. Asit says, results are received with highest accuracy within 4 hours of sample collection.

Diagrite has partnered with hundreds of laboratories across India, and samples are sent to the nearest possible location to reduce TAT of medical reports and ensure efficacy.

With its presence already in 26 cities in India, the company aims to expand globally, especially in countries that lack access to good medical facilities. According to Puneet Sharma, COO, Diagrite, Diagright promises to make a significant contribution to Universal Health Coverage (UHC) and ensure good health and well-being across the country.

The health-tech start up not only ensures correct diagnosis to its valued clients, but also adds to the employability of phlebotomists, thereby providing them financial support and preparing them to enhance their skills in their dedicated domain .

Diagrite aims to carve a niche for itself by employing over 2 million phlebotomists in the coming years and is the only company to soon have the largest fleet of phlebotomists.

Disclaimer: This is a news published directly from IANS News Feed. With this, the News Nation team has not done any editing of any kind. In such a situation, any responsibility regarding the related news will be of the news agency itself.